MiR-329 suppresses the growth and motility of neuroblastoma by targeting KDM1A

FEBS Letters

Volumn 588, Issue 1, 2014, Pages 192-197

  Yang, Haifeng ^a   Li, Qi ^a   Zhao, Wohua ^a   Yuan, Dun ^a   Zhao, Hongyang ^a   Zhou, Yong ^a  

^a HUAZHONG UNIVERSITY OF SCIENCE AND TECHNOLOGY   (China)

Author keywords

Growth; Invasion; KDM1A; Migration; miR 329; Neuroblastoma

Indexed keywords

CELL ENZYME; LYSINE SPECIFIC DEMETHYLASE 1; MICRORNA; MICRORNA 329; UNCLASSIFIED DRUG; CELL PROTEIN; SHORT HAIRPIN RNA;

ANTINEOPLASTIC ACTIVITY; ANTIPROLIFERATIVE ACTIVITY; ARTICLE; CANCER CELL CULTURE; CANCER INHIBITION; COLONY FORMATION; CONTROLLED STUDY; DISEASE ACTIVITY; DOWN REGULATION; DRUG EFFECT; DRUG MECHANISM; DRUG TARGETING; ENZYME ACTIVITY; ENZYME ASSAY; GROWTH INHIBITION; HUMAN; HUMAN CELL; HUMAN TISSUE; MIGRATION INHIBITION; MOLECULAR DYNAMICS; MOLECULAR PATHOLOGY; NEUROBLASTOMA; PRIORITY JOURNAL; TUMOR INVASION; CELL INVASION; CELL MIGRATION; CELL MOTILITY; CELL PROLIFERATION; CELL VIABILITY; EMBRYO; ENZYME INHIBITION; GENE OVEREXPRESSION; IN VITRO STUDY; METASTASIS INHIBITION; NEUROBLASTOMA CELL; PROTEIN EXPRESSION; REAL TIME POLYMERASE CHAIN REACTION; WESTERN BLOTTING;

EID: 84891021006     PISSN: 00145793     EISSN: 18733468     Source Type: Journal    
DOI: 10.1016/j.febslet.2013.11.036     Document Type: Article

References (21)

1. R. Torkin, J.F. Lavoie, D.R. Kaplan, and H. Yeger Induction of caspase-dependent, p53-mediated apoptosis by apigenin in human neuroblastoma Mol. Cancer Ther. 4 2005 1 11
2. J.M. Maris Recent advances in neuroblastoma N. Engl. J. Med. 362 2010 2202 2211
3. J. Guo et al. Identification of miRNAs that are associated with tumor metastasis in neuroblastoma Cancer Biol. Ther. 9 2010 446 452
4. J. Qiao, S. Lee, P. Paul, L. Theiss, J. Tiao, L. Qiao, A. Kong, and D.H. Chung MiR-335 and miR-363 regulation of neuroblastoma tumorigenesis and metastasis Surgery 154 2013 226 233
5. R. Garzon, G.A. Calin, and C.M. Croce MicroRNAs in cancer Annu. Rev. Med. 60 2009 167 179
6. J.H. Schulte et al. Accurate prediction of neuroblastoma outcome based on miRNA expression profiles Int. J. Cancer 127 2010 2374 2385
7. Y. Chen, and R.L. Stallings Differential patterns of microRNA expression in neuroblastoma are correlated with prognosis, differentiation, and apoptosis Cancer Res. 67 2007 976 983
8. K. Althoff et al. MiR-137 functions as a tumor suppressor in neuroblastoma by downregulating KDM1A Int. J. Cancer 133 2013 1064 1073
9. X. Chen, M. Pan, L. Han, H. Lu, X. Hao, and Q. Dong MiR-338-3p suppresses neuroblastoma proliferation, invasion and migration through targeting PREX2a FEBS Lett. 587 2013 3729 3737
10. P. Wang et al. MicroRNA 329 suppresses angiogenesis by targeting CD146 Mol. Cell. Biol. 33 2013 3689 3699
11. D.Z. Liu, B.P. Ander, Y. Tian, B. Stamova, G.C. Jickling, R.R. Davis, and F.R. Sharp Integrated analysis of mRNA and microRNA expression in mature neurons, neural progenitor cells and neuroblastoma cells Gene 495 2012 120 127
12. B. Xiao, L. Tan, B. He, Z. Liu, and R. Xu MiRNA-329 targeting E2F1 inhibits cell proliferation in glioma cells J. Transl. Med. 11 2013 172
13. M. Garg, J.A. Potter, and V.M. Abrahams Identification of microRNAs that regulate TLR2-mediated trophoblast apoptosis and inhibition of IL-6 mRNA PLoS One 8 2013 e77249
14. J.H. Schulte et al. Lysine-specific demethylase 1 is strongly expressed in poorly differentiated neuroblastoma: implications for therapy Cancer Res. 69 2009 2065 2071
15. E.C. Kauffman, B.D. Robinson, M.J. Downes, L.G. Powell, M.M. Lee, D.S. Scherr, L.J. Gudas, and N.P. Mongan Role of androgen receptor and associated lysine-demethylase coregulators, LSD1 and JMJD2A, in localized and advanced human bladder cancer Mol. Carcinog. 50 2011 931 944
16. Y. Wang et al. LSD1 is a subunit of the NuRD complex and targets the metastasis programs in breast cancer Cell 138 2009 660 672
17. Z. Huang et al. Lysine-specific demethylase 1 (LSD1/KDM1A) contributes to colorectal tumorigenesis via activation of the Wnt/Beta-catenin pathway by down-regulating Dickkopf-1 (DKK1) PLoS One 8 2013 e70077
18. Y. Yu et al. High expression of lysine-specific demethylase 1 correlates with poor prognosis of patients with esophageal squamous cell carcinoma Biochem. Biophys. Res. Commun. 437 2013 192 198
19. V. Kashyap, S. Ahmad, E.M. Nilsson, L. Helczynski, S. Kenna, J.L. Persson, L.J. Gudas, and N.P. Mongan The lysine specific demethylase-1 (LSD1/KDM1A) regulates VEGF-A expression in prostate cancer Mol. Oncol. 7 2013 555 566
20. D. Jie, Z. Zhongmin, L. Guoqing, L. Sheng, Z. Yi, W. Jing, and Z. Liang Positive expression of LSD1 and negative expression of E-cadherin correlate with metastasis and poor prognosis of colon cancer Dig. Dis. Sci. 58 2013 1581 1589
21. L. Jin, C.L. Hanigan, Y. Wu, W. Wang, B.H. Park, P.M. Woster, and R.A. Casero Loss of LSD1 (lysine-specific demethylase 1) suppresses growth and alters gene expression of human colon cancer cells in a p53- and DNMT1(DNA methyltransferase 1)-independent manner Biochem. J. 449 2013 459 468